Oh dear, what a shocker, including 4m @ 126.83 g/t gold from 38m Awful, horrible, disgraceful even, yup others were right, should've sold
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling